Skip to main content
. Author manuscript; available in PMC: 2021 Aug 23.
Published in final edited form as: Breast Cancer Res Treat. 2020 Apr 11;181(2):423–434. doi: 10.1007/s10549-020-05611-8

Table 5.

Summary of prediction performance of CBCrisk, Manchester formula, and PredictCBC version 1A and version 1B with the corresponding 95% prediction intervals (PI)

Characteristics CBCriska Manchester formulab PredictCBC version 1Ac,d PredictCBC version 1Bc,d
Discrimination
 AUC at 5 years (95% PI) 0.59 (0.54 to 0.64) 0.61 (0.59 to 0.63) 0.63 (0.52 to 0.74) 0.59 (0.46 to 0.71)
 AUC at 10 years (95% PI) 0.58 (0.55 to 0.61) 0.60 (0.58 to 0.62) 0.63 (0.53 to 0.72) 0.59 (0.52 to 0.66)
Calibration
 E/O ratio at 5 years (95% PI) 0.86 (0.20 to 3.75) 1.54 (0.11 to 20.72) 1.26 (0.14 to 11.34) 1.33 (0.14 to 12.76)
 E/O ratio at 10 years (95% PI) 0.82 (0.21 to 3.14) 1.53 (0.13 to 18.52) 1.28 (0.18 to 9.18) 1.35 (0.19 to 10.24)
 Slope (95% PI) 1.26 (1.01 to 1.50) 0.39 (0.34 to 0.43) 0.90 (0.73 to 1.08) 0.81 (0.50 to 1.12)

AUC Area under the curve, PI prediction interval

a

Chowdhury et al. [7]

b

Basu et al. [8]

c

Giardiello et al. [5], Fig. 1 and Figure S5

d

version 1A includes BRCA mutation status as a variable while 1B does not